Back to mobile site

Truist Securities Reiterates Hold Rating on Globus Medical (GMED)

February 24, 2025 2:46 PM EST Send to a Friend
Truist Securities analyst Richard Newitter reiterated a Hold rating and $90.00 price target on Globus Medical (NYSE: GMED)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login